FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016556564> ?p ?o ?g. }

• W2016556564 endingPage "489" @default.
• W2016556564 startingPage "484" @default.
• W2016556564 abstract "Introduction Inhaled steroids are widely used for persistent cough treatment. Although the side effects of long-term inhaled steroids have been well described in the literature, their laryngeal side effects after short-term use have not yet been defined. The aim of this study was to evaluate the effect of 1 month application of inhaled steroid treatment on voice parameters in patients with subacute or chronic cough. Furthermore, the efficacy of inhaled steroids on cough was investigated, as well. Material and Methods This study included 46 patients (27 females and 19 males) with a persistent cough lasting at least 3 weeks and treated with inhaled steroids. All patients were examined by a pulmonologist and lung auscultation where a posteroanterior chest X-ray and spirometry were performed. The patients were also examined by an otolaryngologist. Anterior rhinoscopy, flexible fiberoptic nasopharyngoscopy, and laryngostroboscopy were performed. Also, the patients' acoustic voice analyses were performed and recorded using a multidimensional voice program. Cough symptom index (CSI) scores were used to evaluate the response to treatment. Patients with an underlying disease that was unresponsive to inhaled steroids were excluded from study. The 46 patients were administered inhaled budesonide 400 mcg twice a day, for 1 month, and their acoustic voice analyses were performed again at the end of the treatment. In addition, CSI scores were determined after stopping medication. Results When pretreatment and posttreatment acoustic voice analysis parameters (Fo, Jita, Jitt, Shim, APQ, vAm, and NHR) were compared, statistically significant differences were detected for vAm (P = 0.001) and F0 (P0.003). After treatment with inhaled steroids, the CSI score reduced from 3 to 1 (median), and the difference was statistically significant. Conclusions Inhaled budesonide treatment in the proper dose seems to be an effective treatment for persistent cough, in the selected patient group. In addition, short-term budesonide application did not cause any negative effects on the voice parameters in these patients. These findings may be related to the steroid formulation used, the application method, and the duration of treatment. Further studies are needed on a larger group of patients with different formulations of inhaled steroids to clarify aforementioned issues. Inhaled steroids are widely used for persistent cough treatment. Although the side effects of long-term inhaled steroids have been well described in the literature, their laryngeal side effects after short-term use have not yet been defined. The aim of this study was to evaluate the effect of 1 month application of inhaled steroid treatment on voice parameters in patients with subacute or chronic cough. Furthermore, the efficacy of inhaled steroids on cough was investigated, as well. This study included 46 patients (27 females and 19 males) with a persistent cough lasting at least 3 weeks and treated with inhaled steroids. All patients were examined by a pulmonologist and lung auscultation where a posteroanterior chest X-ray and spirometry were performed. The patients were also examined by an otolaryngologist. Anterior rhinoscopy, flexible fiberoptic nasopharyngoscopy, and laryngostroboscopy were performed. Also, the patients' acoustic voice analyses were performed and recorded using a multidimensional voice program. Cough symptom index (CSI) scores were used to evaluate the response to treatment. Patients with an underlying disease that was unresponsive to inhaled steroids were excluded from study. The 46 patients were administered inhaled budesonide 400 mcg twice a day, for 1 month, and their acoustic voice analyses were performed again at the end of the treatment. In addition, CSI scores were determined after stopping medication. When pretreatment and posttreatment acoustic voice analysis parameters (Fo, Jita, Jitt, Shim, APQ, vAm, and NHR) were compared, statistically significant differences were detected for vAm (P = 0.001) and F0 (P0.003). After treatment with inhaled steroids, the CSI score reduced from 3 to 1 (median), and the difference was statistically significant. Inhaled budesonide treatment in the proper dose seems to be an effective treatment for persistent cough, in the selected patient group. In addition, short-term budesonide application did not cause any negative effects on the voice parameters in these patients. These findings may be related to the steroid formulation used, the application method, and the duration of treatment. Further studies are needed on a larger group of patients with different formulations of inhaled steroids to clarify aforementioned issues." @default.
• W2016556564 created "2016-06-24" @default.
• W2016556564 creator A5013562755 @default.
• W2016556564 creator A5017536789 @default.
• W2016556564 creator A5031178362 @default.
• W2016556564 creator A5037283742 @default.
• W2016556564 creator A5061125772 @default.
• W2016556564 creator A5065432096 @default.
• W2016556564 creator A5091528975 @default.
• W2016556564 date "2015-07-01" @default.
• W2016556564 modified "2023-10-16" @default.
• W2016556564 title "Voice Assessment After Treatment of Subacute and Chronic Cough With Inhaled Steroids" @default.
• W2016556564 cites W1967819079 @default.
• W2016556564 cites W1968951989 @default.
• W2016556564 cites W1988811465 @default.
• W2016556564 cites W2000027105 @default.
• W2016556564 cites W2002796983 @default.
• W2016556564 cites W2009478977 @default.
• W2016556564 cites W2019643126 @default.
• W2016556564 cites W2024199198 @default.
• W2016556564 cites W2025445889 @default.
• W2016556564 cites W2039020136 @default.
• W2016556564 cites W2040939442 @default.
• W2016556564 cites W2065065939 @default.
• W2016556564 cites W2068391562 @default.
• W2016556564 cites W2069226742 @default.
• W2016556564 cites W2069793722 @default.
• W2016556564 cites W2073091112 @default.
• W2016556564 cites W2079655668 @default.
• W2016556564 cites W2088140593 @default.
• W2016556564 cites W2094775402 @default.
• W2016556564 cites W2099917331 @default.
• W2016556564 cites W2110106141 @default.
• W2016556564 cites W2152488127 @default.
• W2016556564 cites W2158674017 @default.
• W2016556564 cites W2165291348 @default.
• W2016556564 cites W2171384067 @default.
• W2016556564 doi "https://doi.org/10.1016/j.jvoice.2014.09.007" @default.
• W2016556564 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25704467" @default.
• W2016556564 hasPublicationYear "2015" @default.
• W2016556564 type Work @default.
• W2016556564 sameAs 2016556564 @default.
• W2016556564 citedByCount "3" @default.
• W2016556564 countsByYear W20165565642016 @default.
• W2016556564 countsByYear W20165565642021 @default.
• W2016556564 crossrefType "journal-article" @default.
• W2016556564 hasAuthorship W2016556564A5013562755 @default.
• W2016556564 hasAuthorship W2016556564A5017536789 @default.
• W2016556564 hasAuthorship W2016556564A5031178362 @default.
• W2016556564 hasAuthorship W2016556564A5037283742 @default.
• W2016556564 hasAuthorship W2016556564A5061125772 @default.
• W2016556564 hasAuthorship W2016556564A5065432096 @default.
• W2016556564 hasAuthorship W2016556564A5091528975 @default.
• W2016556564 hasConcept C108516343 @default.
• W2016556564 hasConcept C126322002 @default.
• W2016556564 hasConcept C141071460 @default.
• W2016556564 hasConcept C2776042228 @default.
• W2016556564 hasConcept C2776136866 @default.
• W2016556564 hasConcept C2776954882 @default.
• W2016556564 hasConcept C2777324038 @default.
• W2016556564 hasConcept C2777707825 @default.
• W2016556564 hasConcept C2777714996 @default.
• W2016556564 hasConcept C2780333948 @default.
• W2016556564 hasConcept C2780908675 @default.
• W2016556564 hasConcept C42219234 @default.
• W2016556564 hasConcept C71924100 @default.
• W2016556564 hasConceptScore W2016556564C108516343 @default.
• W2016556564 hasConceptScore W2016556564C126322002 @default.
• W2016556564 hasConceptScore W2016556564C141071460 @default.
• W2016556564 hasConceptScore W2016556564C2776042228 @default.
• W2016556564 hasConceptScore W2016556564C2776136866 @default.
• W2016556564 hasConceptScore W2016556564C2776954882 @default.
• W2016556564 hasConceptScore W2016556564C2777324038 @default.
• W2016556564 hasConceptScore W2016556564C2777707825 @default.
• W2016556564 hasConceptScore W2016556564C2777714996 @default.
• W2016556564 hasConceptScore W2016556564C2780333948 @default.
• W2016556564 hasConceptScore W2016556564C2780908675 @default.
• W2016556564 hasConceptScore W2016556564C42219234 @default.
• W2016556564 hasConceptScore W2016556564C71924100 @default.
• W2016556564 hasIssue "4" @default.
• W2016556564 hasLocation W20165565641 @default.
• W2016556564 hasLocation W20165565642 @default.
• W2016556564 hasOpenAccess W2016556564 @default.
• W2016556564 hasPrimaryLocation W20165565641 @default.
• W2016556564 hasRelatedWork W142758785 @default.
• W2016556564 hasRelatedWork W2027832520 @default.
• W2016556564 hasRelatedWork W2034312637 @default.
• W2016556564 hasRelatedWork W2069431809 @default.
• W2016556564 hasRelatedWork W2162130040 @default.
• W2016556564 hasRelatedWork W2361846890 @default.
• W2016556564 hasRelatedWork W2401381624 @default.
• W2016556564 hasRelatedWork W2964843488 @default.
• W2016556564 hasRelatedWork W3030145202 @default.
• W2016556564 hasRelatedWork W4249858658 @default.
• W2016556564 hasVolume "29" @default.
• W2016556564 isParatext "false" @default.
• W2016556564 isRetracted "false" @default.
• W2016556564 magId "2016556564" @default.

• next